Navigation Links
Manchester clears first hurdle in €170 million biobank building boom
Date:6/19/2008

The University of Manchester has been successful in gaining major European Union funding to begin joint planning of how millions of biological samples, such as DNA, can be managed and made available to research scientists across Europe.

The Centre for Integrated Genomic Medical Research (CIGMR), based in the School of Translational Medicine, is playing a key role in developing the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) alongside scientists and funding agencies in other European member states.

This infrastructure will link new and existing biobanks across the continent and planners anticipate the cost of construction will exceed 170 million.

The initial planning phase will last two years and cost 5 million, the sum announced today (Thursday). It will answer key questions, including whether the infrastructure will comprise a number of physical buildings in locations across Europe or whether a virtual infrastructure would be the best option, or a combination of both.

Dr Martin Yuille, Reader in Biological Resource Management and associate coordinator for the planning phase, said: "This European biobanking infrastructure is as important to biomedical science as CERN is to Physics or Jodrell is to Astronomy.

"It will counter fragmentation in Europe that is impeding access to valuable resources essential for translating the human genome sequence into health benefits."

Advances in robotics, miniaturisation and imaging are allowing detailed molecular analysis of biological samples. For biomedicine this means that samples from very large numbers of patients and healthy individuals need to be studied to discover, for example, the genes that underlie our risk of diseases like heart disease, cancer or Alzheimer's.

Manchester is already a leading centre for this area of research. It is host to the UK Biobank - a world-leading study of how genes and lifestyle contribute to health
'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Page: 1 2

Related biology news :

1. Queens University launches UKs first Center of Excellence for Public Health
2. First successful reverse vasectomy on endangered species performed at the National Zoo
3. Professor Brian Greenwood awarded first Hideyo Noguchi Africa Award
4. Leiden scientists sequence first female DNA
5. Precourt Institute for Energy Efficiency awards first faculty research grants
6. IEEE Fellow first woman to receive highest award in engineering profession
7. Pioneering landscape-scale research releases first findings
8. BIO-key(R) Reports First Quarter 2008 Results
9. Scientists decipher fruit tree genome for the first time
10. BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule
11. First analysis of platypus genome may impact disease prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... developed a protein therapy that disrupts the process that ... sites, travel through the blood stream and start aggressive ... known as metastasis, can cause cancer to spread with ... succumb to cancer fall prey to metastatic forms of ... bioengineering who describes a new therapeutic approach in ...
(Date:9/19/2014)... fairness did not evolve for the sake of fairness ... of continued cooperation, so say Frans de Waal, PhD, ... about inequity aversion (IA), which is defined as a ... in Science . , Their conclusion comes ... to address their hypothesis that it is the evolution ...
(Date:9/18/2014)... A new GSA Bulletin study uses ... Rio Puerco and Chaco Wash in northern New Mexico, ... salt cedar and willow, investigators were able to precisely ... They then combined this data with aerial imagery, LiDAR, ... of these arroyos. , Arroyos are deep, oversized channels ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7
... as to how HIV evades the human immune system ... The findings suggest some HIV vaccines may have failed ... patient's own immune system is programmed to destroy. , ... which recognize and latch onto the HIV protein gp41, ...
... Africa, where days of heavy rains and flooding have led ... are reporting an unprecedented rise in Somalia's Shabelle River and ... centre of the country, the United Nations said today. , ... Affairs (OCHA), reports yesterday from Belet Weyne, close to the ...
... to recover in adolescent females once they stop using ... a study funded by the National Institute of Child ... Health. , Previous studies had shown that women who ... a loss of bone mineral density during the time ...
Cached Biology News:New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines 2New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines 3Bone Density Recovers After Teens Stop Injected Contraceptive 2Bone Density Recovers After Teens Stop Injected Contraceptive 3
(Date:9/19/2014)... 19, 2014  Nektar Therapeutics (NASDAQ: ... characterizing the analgesic profiles of a series of ... agonist molecules. The preclinical research candidates were created ... The analgesic properties of kappa receptor ... 1,2 Kappa opioid receptors are expressed in ...
(Date:9/19/2014)... Dublin ... announced the addition of the  "Micro Market Monitor ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... fastest-growing segments in the chromatography market. The market ... expected to reach $2.0 billion by 2019, at ...
(Date:9/18/2014)... LONDON , Sept. 18, 2014 ... near-patient testing, is performed outside a clinical laboratory. ... hence in administrating appropriate treatments and medication. POCT ... and prevalence of lifestyle diseases such as diabetes, ... and user-friendly. POCT devices are standardized to minimize ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Texas ... John Sharp, Texas A&M Health Science Center CEO ... Department of Health and Human Services (HHS), State ... a national pandemic influenza vaccine manufacturing facility in ... an anchor for the Texas A&M Biocorridor – ...
Breaking Biology Technology:Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Micro Market Monitor : Global Pre-packed Chromatography Columns 2POCT Market in China 2014-2018 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4
... KBI Biopharma, Inc. (KBI) announced today that it ... with Crucell,s PER.C6(R) human cell line platform, pursuant to ... 6, 2009. Under that agreement, KBI joins the Vendor ... for licensees of the PER.C6(R) cell lines. , ...
... International Products Corporation,s ( http://www.ipcol.com ) ... membrane compatibility and performance studies using a versatile ... any type of membrane media, from UF to RO, and ... "Our goal is to be able to recommend the most ...
... Release Highlights, - Melogliptin continues to demonstrate potential to ... low incidence of, hypoglycemia and neutral effect on ... by end 2009, - IND approved by USFDA, ... Indian company to have a truly global innovative drug for ...
Cached Biology Technology:KBI Biopharma Starts Cell Line Generation Process under Vendor Network Agreement for PER.C6(R) 2International Products Corp.'s Lab Offers Filter Membrane Compatibility and Studies 2Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials 2